Recent insights into the immune profile of prostate tumors reveal a microenvironment rich in immunosuppressive myeloid cells as well as T-cell exhaustion signatures, such as increased PD-1 or PD-L1 [51,52]. The gene discussed is CD274; the disease is prostate neoplasm.